HHC (hexahydrocannabinol), a cannabinoid typically produced by hydrogenating hemp-derived CBD rather than extracted directly from the plant, continues to face a more restrictive legal landscape than Delta-8 or THCA as more states move to ban "synthetic" or chemically-converted cannabinoids specifically.
Because HHC rarely occurs naturally in the plant in commercially meaningful quantities, states that distinguish between naturally-occurring and lab-converted hemp derivatives frequently name it directly in restrictive statutes — a different legal posture than the broader "any hemp-derived THC isomer" bans that typically also capture Delta-8 and Delta-10.
The category's treatment under the incoming federal total-THC standard remains somewhat unsettled pending FDA's required implementation guidance. Our HHC legal status explainer covers the current state-by-state landscape.
Sources: Cannabis Inquirer, HempData.